Which products and versions are affected by CVE-2020-15050?

Affected: Biostar 2 (Supremainc). The full list is in the CVE brief.

Is CVE-2020-15050 being exploited in the wild?

It is not listed in any known-exploited vulnerabilities catalog.

Is CVE-2020-15050 in the CISA KEV catalog?

No, it is not currently listed in the CISA Known Exploited Vulnerabilities catalog.

Is there a public exploit for CVE-2020-15050?

Public exploit code is available.

Is there a fix for CVE-2020-15050?

Fixed versions are available, including Biostar 2 2.8.2.

How urgently should CVE-2020-15050 be patched?

Brandefense priority: patch immediately, because it is very likely to be exploited soon.

Request A Demo

Vulnerability Intelligence

CVE-2020-15050

HighPublic exploit

Remote attackers can read arbitrary files from the server via Directory Traversal.

Published Jul 13, 2020 · Updated Nov 21, 2024

Key Facts

Patch immediately

CVE-2020-15050 is a high-severity vulnerability (CVSS 7.5 v3.1) affecting Biostar 2 (Supremainc).
It is not listed in any known-exploited vulnerabilities catalog. Public exploit code is available.
EPSS estimates a 51% probability of exploitation in the next 30 days.
Fixed versions are available, including Biostar 2 2.8.2.
Brandefense priority: patch immediately, because it is very likely to be exploited soon.

CVSS v3.1

7.5

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N

EPSS (30-day exploit likelihood)

51%

Higher than 98.9% of all scored CVEs

Exploited in the wild

No known

Not in a known-exploited catalog

Public exploit code

Available

Proof-of-concept or weaponized module

Get the full CVE-2020-15050 brief as a PDF

Every affected product and fixed release, exploitation status and a first 24 hours response checklist, emailed within minutes.

Description

An issue was discovered in the Video Extension in Suprema BioStar 2 before 2.8.2. Remote attackers can read arbitrary files from the server via Directory Traversal.

Affected Products

1 affected entries in total

Product	Affected versions	Fixed in
Biostar 2Supremainc	See advisory	2.8.2

Patched Releases

Biostar 2

2.8.2

Timeline

Publicly disclosed
Jul 13, 2020
Last updated
Nov 21, 2024

Weakness Type

CWE-22 Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal')

References

FAQ

Common Questions.

An issue was discovered in the Video Extension in Suprema BioStar 2 before 2.8.2.
Affected: Biostar 2 (Supremainc). The full list is in the CVE brief.
It is not listed in any known-exploited vulnerabilities catalog.
No, it is not currently listed in the CISA Known Exploited Vulnerabilities catalog.
Public exploit code is available.
Fixed versions are available, including Biostar 2 2.8.2.
Brandefense priority: patch immediately, because it is very likely to be exploited soon.

Is CVE-2020-15050 Running On Your Attack Surface?

Brandefense maps vulnerabilities like this one to your internet-facing assets and tells you exactly where to patch.